Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/126909
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | San Juan, Rafael | - |
dc.contributor.author | Viedma, Esther | - |
dc.contributor.author | Chaves, Fernando | - |
dc.contributor.author | Lalueza, Antonio | - |
dc.contributor.author | Fortún, Jesús | - |
dc.contributor.author | Loza, Elena | - |
dc.contributor.author | Pujol Rojo, Miquel | - |
dc.contributor.author | Ardanuy Tisaire, María Carmen | - |
dc.contributor.author | Morales, Isabel | - |
dc.contributor.author | Cueto, Marina de | - |
dc.contributor.author | Resino Foz, Elena | - |
dc.contributor.author | Morales Cartagena, Alejandra | - |
dc.contributor.author | Rico, Alicia | - |
dc.contributor.author | Romero, María P. | - |
dc.contributor.author | Orellana, María Ángeles | - |
dc.contributor.author | López Medrano, Francisco | - |
dc.contributor.author | Fernández Ruiz, Mario | - |
dc.contributor.author | Aguado, José María | - |
dc.date.accessioned | 2018-12-11T13:21:26Z | - |
dc.date.available | 2018-12-11T13:21:26Z | - |
dc.date.issued | 2016-06 | - |
dc.identifier.issn | 1080-6040 | - |
dc.identifier.uri | https://hdl.handle.net/2445/126909 | - |
dc.description.abstract | We investigated the prognostic role of high MICs for antistaphylococcal agents in patients with methicillin-sensitive Staphylococcus aureus catheter-related bloodstream infection (MSSA CRBSI). We prospectively reviewed 83 episodes from 5 centers in Spain during April 2011 June 2014 that had optimized clinical management and analyzed the relationship between E-test MICs for vancomycin, daptomycin, oxacillin, and linezolid and development of complicated bacteremia by using multivariate analysis. Complicated MSSA CRBSI occurred in 26 (31.3%) patients; MICs for vancomycin and daptomycin were higher in these patients (optimal cutoff values for predictive accuracy = 1.5 mu g/mL and 0.5 mu g/mL). High MICs for vancomycin (hazard ratio 2.4, 95% CI 1.2-5.5) and daptomycin (hazard ratio 2.4, 95% CI 1.1-5.9) were independent risk factors for development of complicated MSSA CRBSI. Our data suggest that patients with MSSA CRBSI caused by strains that have high MICs for vancomycin or daptomycin are at increased risk for complications. | - |
dc.format.extent | 10 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Centers for Disease Control and Prevention | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.3201/eid2206.151709 | - |
dc.relation.ispartof | Emerging Infectious Diseases, 2016, vol. 22, num. 6, p. 1057-1066 | - |
dc.relation.uri | https://doi.org/10.3201/eid2206.151709 | - |
dc.rights | , 2016 | - |
dc.source | Articles publicats en revistes (Patologia i Terapèutica Experimental) | - |
dc.subject.classification | Sang | - |
dc.subject.classification | Malalties bacterianes | - |
dc.subject.classification | Factors de risc en les malalties | - |
dc.subject.classification | Efecte dels medicaments sobre els microorganismes | - |
dc.subject.other | Blood | - |
dc.subject.other | Bacterial diseases | - |
dc.subject.other | Risk factors in diseases | - |
dc.subject.other | Effect of drugs on microorganisms | - |
dc.title | High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive Staphylococcus aureus | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 662472 | - |
dc.date.updated | 2018-12-11T13:21:26Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 27192097 | - |
Appears in Collections: | Articles publicats en revistes (Patologia i Terapèutica Experimental) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
662472.pdf | 1.55 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.